SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Link Pharma Chem - Quaterly Results

11 Nov 2024 Evaluate
The sales for the September 2024 quarter moved down to Rs. 47.98 millions as compared to Rs. 60.50 millions during the year-ago period.The Net Loss for the quarter ended September 2024 is Rs. -3.06 millions as compared to Net Loss of Rs. -10.21 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to 0.56% as compared to -9.12% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 47.98 60.50 -20.69 136.44 139.26 -2.02 298.98 387.58 -22.86
Other Income 3.59 -0.26 -1480.77 6.31 2.81 124.56 6.40 -1.47 -535.37
PBIDT 0.56 -9.12 -106.14 8.72 -15.68 -155.61 -0.09 25.69 -100.35
Interest 2.09 2.18 -4.13 4.29 4.47 -4.03 8.72 7.61 14.59
PBDT -1.53 -11.30 -86.46 4.43 -20.15 -121.99 -8.81 18.08 -148.73
Depreciation 2.36 2.61 -9.58 4.71 5.19 -9.25 10.34 9.23 12.03
PBT -3.89 -13.91 -72.03 -0.28 -25.34 -98.90 -19.15 8.85 -316.38
TAX -0.83 -3.70 -77.57 -0.19 -6.89 -97.24 -5.53 2.32 -338.36
Deferred Tax -0.83 -3.76 -77.93 -0.19 -6.95 -97.27 -5.59 -1.83 205.46
PAT -3.06 -10.21 -70.03 -0.09 -18.45 -99.51 -13.62 6.53 -308.58
Equity 44.41 44.41 0.00 44.41 44.41 0.00 44.41 44.41 0.00
PBIDTM(%) 1.17 -15.07 -107.74 6.39 -11.26 -156.76 -0.03 6.63 -100.45

Link Pharma Chem Share Price

30.98 1.52 (5.16%)
16-Apr-2026 09:47 View Price Chart
Peers
Company Name CMP
BASF India 3667.20
Tata Chemicals 716.00
SRF 2500.20
Pidilite Inds. 1328.40
Deepak Nitrite 1513.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×